Monoclonal Antibodies Weekly
Susan Hasty, Publisher
Table of Contents . . . May 24th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Monoclonal Antibodies Weekly | Other Publications
Cancer Therapy - In vivo Response Mediated Through Fc Receptor Activation
Allograft Tolerance - Immunosuppression Induced by MAbs and Cyclosporine
Rabies Virus - Monoclonal Antibodies Target Viral Phosphoprotein for Strain Discrimination
Systemic Lupus Erythematosus - Monoclonal Anti-Double-Stranded DNA Autoantibody Involved in Pathogenesis
Xenograft Tolerance - Survival Prolonged by MAb CD45RB and Cyclophosphamide
Anti-Angiogenesis - Antibody Fragments Target Activated Form of Vitronectin
Antithrombosis - Hemostatic Effects of Platelet Inhibitors, Low-Molecular-Weight Heparin Assessed
Bone Antigens - Monoclonal Antibody Recognizes a Bone Matrix Protein
Vascular Permeability - MAbs Against VE-Cadherin and VEGFR-2 Modulate Vascular Permeability
Cancer Vaccines - TNF(alpha) Vaccine Induces Immune Responses Against Self Proteins
Leukemia - Emerging Chemotherapeutic Agents Reported to Drive Growth of Therapy Market
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
